高级检索

黄芩苷纳米药物对过氧化氢诱导的人脐静脉血管内皮细胞衰老的改善作用

Ameliorative effect of baicalin nanomedicine on hydrogen peroxide-induced senescence of human umbilical vein vascular endothelial cells

  • 摘要: 为了探讨负载黄芩苷(BAI)的交联硫辛酸纳米胶囊(BAI@cLANCs)对过氧化氢(H2O2)诱导的人脐静脉血管内皮细胞(HUVECs)衰老的影响,采用MTT法考察BAI@cLANCs的HUVECs毒性;MTT法、细胞核染色法、SA-β-gal染色法确定H2O2诱导HUVECs衰老的最佳浓度;荧光显微镜成像法、流式细胞术评估BAI@cLANCs的细胞摄取效果;SA-β-gal染色法测定细胞衰老比例,荧光显微镜成像法、多功能酶标仪检测衰老细胞中活性氧(ROS)水平,脂质氧化检测试剂盒检测细胞内丙二醛(MDA)含量,碘化丙啶单染流式细胞术分析细胞周期。结果显示:BAI@cLANCs(以BAI的浓度进行定量)在2.80~112 mmol/L范围内对HUVECs生长无显著影响;H2O2诱导HUVECs衰老的最佳条件为200 μmol/L、25 min;cLANCs作为药物递送载体能显著增强BAI在HUVECs上的摄取效率;与正常组相比,H2O2模型组细胞活力下降,SA-β-gal染色阳性率增高,ROS、MDA含量增多,细胞阻滞于S期,进入G2/M期的细胞减少;与H2O2模型组相比,BAI组、cLANCs组、BAI + cLANCs组、BAI@cLANCs组细胞活力升高,SA-β-gal染色阳性率降低,ROS、MDA含量减少,S期细胞百分比降低,进入G2/M期的细胞增加,其中BAI@cLANCs组抗衰老效果最佳。研究结果表明,BAI与cLANCs均具有抗衰老活性,以cLANCs作为药物载体来负载BAI制成的BAI@cLANCs存在联合抗衰老的优势,可有效延缓H2O2诱导的HUVECs衰老。

     

    Abstract: To investigate the effect of baicalin (BAI)-loaded cross-linked lipoic acid nanocapsules (BAI@cLANCs) against hydrogen peroxide (H2O2)-induced senescence in human umbilical vein endothelial cells (HUVECs), this study examined the toxicity of BAI@cLANCs on HUVECs by MTT method. The cell nuclear staining, SA-β-gal staining, and MTT methods were used to assess the optimal concentration of H2O2-induced senescence in HUVECs. The cellular uptake of BAI@cLANCs was evaluated using fluorescence microscopy imaging and flow cytometry. The proportion of cellular senescence was determined by SA-β-gal staining. The level of reactive oxygen species (ROS) in senescent cells was detected by fluorescence microscopy imaging and multifunctional microplate reader. The content of malondialdehyde (MDA) in cells was detected by lipid oxidation detection kit, and the cell cycle was analyzed by flow cytometry with propidium iodide staining. The results showed that BAI@cLANCs had no significant effect on the growth of HUVECs in the range of BAI at 2.80−112 mmol/L. 200 μmol/L and 25 minutes were the ideal conditions for H2O2-induced senescence of HUVECs. cLANCs as drug delivery carriers significantly enhanced the uptake efficiency of BAI in HUVECs. Compared with the normal group, the H2O2 model group showed decreased cell viability, increased positive SA-β-gal staining rate, increased ROS and MDA content, as well as increased percentage of cells blocked in S phase and decreased cells entering G2/M phase. Compared with the H2O2 model group, BAI, cLANCs, BAI + cLANCs, and BAI@cLANCs groups showed increased cell viability, decreased positive SA-β-gal staining rate, decreased ROS and MDA content, decreased percentage of S-phase cells, and increased cells entering G2/M phase, with the best anti-aging effect in the BAI@cLANCs group. In summary, the results above showed that both BAI and cLANCs have anti-aging properties. With cLANCs as drug carriers, the anti-aging benefits of BAI@cLANCs are synergistic and can effectively delay H2O2-induced senescence of HUVECs.

     

/

返回文章
返回